Establishment of a highly migratory subclone reveals that CD133 contributes to migration and invasion through epithelial–mesenchymal transition in pancreatic cancer

Abstract 433: Role of AQP1 in invasion of GBM

(2011) Gay Samuelson et al.   CANCER RESEARCH

Development of a highly metastatic model that reveals a crucial role of fibronectin in lung cancer cell migration and invasion

(2010) Deshui Jia et al.   BMC CANCER

AACR Special Conference on Epithelial-Mesenchymal Transition and Cancer Progression and Treatment

(2010) E. T. Roussos et al.   CANCER RESEARCH

AACR Centennial Series: The Biology of Cancer Metastasis: Historical Perspective

(2010) J. E. Talmadge et al.   CANCER RESEARCH

The Stem Cell Marker CD133 (Prominin-1) is Phosphorylated on Cytoplasmic Tyrosine-828 and Tyrosine-852 by Src and Fyn Tyrosine Kinases

(2009) Dominique Boivin et al.   BIOCHEMISTRY

EMT: When epithelial cells decide to become mesenchymal-like cells

(2009) Raghu Kalluri   JOURNAL OF CLINICAL INVESTIGATION

The basics of epithelial-mesenchymal transition

(2009) Raghu Kalluri et al.   JOURNAL OF CLINICAL INVESTIGATION

Regulation of Renal Epithelial Tight Junctions by the von Hippel-Lindau Tumor Suppressor Gene Involves Occludin and Claudin 1 and Is Independent of E-Cadherin

(2008) Sarah K. Harten et al.   MOLECULAR BIOLOGY OF THE CELL

Stimulation of lung carcinoma cell growth by fibronectin–integrin signalling

(2008) Jeffrey D. Ritzenthaler et al.   Molecular BioSystems

The Stem Cell-Associated Antigen CD133 (Prominin-1) Is a Molecular Therapeutic Target for Metastatic Melanoma

(2008) Germana Rappa et al.   STEM CELLS

CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells

(2007) Jian Wang et al.   INTERNATIONAL JOURNAL OF CANCER